Does the Amount of Malignant Pleural Effusion Affect the Survival in Patients with Non-Small Cell Lung Cancer?

被引：0
|
作者：
Nakamura, Shota [1 ]
Okasaka, Toshiki [1 ]
Kawaguchi, Koji [1 ]
Fukui, Takayuki [1 ]
Fukumoto, Koichi [1 ]
Yokoi, Kohei [1 ]
机构：
[1] Nagoya Univ, Thorac Surg, Nagoya, Aichi 4648601, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
non-small cell lung cancer; TNM classification; malignant pleural effusion; malignant pleuritis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.04-128
引用
收藏
页码：S727 / S727
页数：1
相关论文
共 50 条
  • [21] Clinical course of asymptomatic malignant pleural effusion in non-small cell lung cancer patients A multicenter retrospective study
    Roh, Jiyeon
    Ahn, Hyo Yeong
    Kim, Insu
    Son, Ju Hyeong
    Seol, Hee Yun
    Kim, Mi Hyun
    Lee, Min Ki
    Eom, Jung Seop
    MEDICINE, 2021, 100 (19) : E25748
  • [22] Evaluation Of The Lent Score As A Prognostic Predictor Of Non-Small Cell Lung Cancer With Malignant Pleural Effusion
    Kato, T.
    Hirose, T.
    Matsui, H.
    Masuda, K.
    Tamura, A.
    Funabiki, A.
    Nakamura, S.
    Mori, A.
    Akashi, S.
    Shimada, M.
    Akagawa, S.
    Kitani, M.
    Hebisawa, A.
    Ohta, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [23] Treatment of malignant pleural effusion in non-small cell lung cancer with VEGF-directed therapy
    Xiang, Zhangqiang
    Deng, Xiangyu
    He, Wenfeng
    Yang, Qian
    Ni, Laichao
    Dehghan Shasaltaneh, Marzieh
    Maghsoudloo, Mazaher
    Yang, Gang
    Wu, Jingbo
    Imani, Saber
    Wen, Qinglian
    ANNALS OF MEDICINE, 2022, 54 (01) : 1357 - 1371
  • [24] The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer
    Wang, Yumin
    Chen, Zengqiang
    Chen, Jie
    Pan, Jingye
    Zhang, Wenhui
    Pan, Qinshi
    Ding, Hongyan
    Lin, Xiaomei
    Wen, Xiushu
    Li, Yangyang
    Meng, Qing H.
    CLINICA CHIMICA ACTA, 2013, 421 : 230 - 235
  • [25] THE EFFECT OF CARBOPLATIN PACLITAXEL AND BEVACIZUMAB FOR ADVANCED NON-SMALL CELL LUNG CANCER WITH MALIGNANT PLEURAL EFFUSION
    Kazuyori, Taisuke
    Tamura, Nobumasa
    Sasaki, Ryoko
    Hirano, Yuuta
    Tone, Kazuya
    Shinohara, Wakako
    Kojima, Akira
    Kuwano, Kazuyoshi
    RESPIROLOGY, 2017, 22 : 116 - 116
  • [26] Permanent pleural catheter (PPC) for malignant pleural effusion (PE) in advanced non-small cell lung cancer (NSCLC)
    Martinez Kareaga, M.
    Urbieta-Macazaga, N.
    Sanchez-Vieco, C.
    Tomas-Lopez, L.
    Intxaurbe-Etxebarria, I.
    Mareque, B.
    Torrego, N.
    Narro, A.
    Punti, L.
    Guillen, I.
    ANNALS OF ONCOLOGY, 2019, 30 : 63 - 63
  • [27] Molecular Profiling of Malignant Pleural Effusion in Metastatic Non-Small Cell Lung Carcinoma
    Carter, Jamal H.
    Miller, James A.
    Maleki, Zahra
    LABORATORY INVESTIGATION, 2016, 96 : 94A - 94A
  • [28] Molecular Profiling of Malignant Pleural Effusion in Metastatic Non-Small Cell Lung Carcinoma
    Carter, Jamal H.
    Miller, James A.
    Maleki, Zahra
    MODERN PATHOLOGY, 2016, 29 : 94A - 94A
  • [29] Malignant Pleural Effusion at Presentation in Patients with Small-Cell Lung Cancer
    Shojaee, Samira
    Singh, Inderjit
    Solsky, Ian
    Nana-Sinkam, Patrick
    RESPIRATION, 2019, 98 (03) : 198 - 202
  • [30] Prognostic significance of minimal pleural effusion in non-small cell lung cancer patients.
    Ryu, Jeong Seon
    Lee, Si-Nae
    Ryu, Hyo-Jin
    Nam, Hae-Seong
    Memon, Azra
    Kim, Hyun-Jung
    Lim, Joo Han
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345